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Abstract Cognitive behavioral therapy (CBT) is gener-
ally considered the recommended approach for selective
mutism (SM). Prospective follow-up studies of treated SM
and predictors of outcome are scarce. We have developed a
CBT home and school-based intervention for children with
SM previously found to increase speech in a pilot efficacy
study and in a randomized controlled treatment study. In
the present report we provide outcome data 1 year after
having completed the 6-month course of CBT for 24
children with SM, aged 3–9 years (mean age 6.5 years, 16
girls). Primary outcome measures were the teacher rated
School Speech Questionnaire (SSQ) and diagnostic status.
At follow-up, no significant decline was found on the SSQ
scores. Age and severity of SM had a significant effect
upon outcome, as measured by the SSQ. Eight children still
fulfilled diagnostic criteria for SM, four were in remission,
and 12 children were without diagnosis. Younger children
improved more, as 78 % of the children aged 3–5 years did
not have SM, compared with 33 % of children aged
6–9 years. Treatment gain was upheld at follow-up.
Greater improvement in the younger children highlights the
importance of an early intervention.
Keywords Selective mutism  Follow-up  Behavioural
intervention  Social phobia  Childhood anxiety
Introduction
Children with selective mutism (SM) are characterized by a
consistent lack of speech in specific social situations in
which there is an expectation for speaking (e.g. school)
despite speaking in other situations (e.g. at home) [1]. Age
of onset is typically before age 5 years [2, 3]. SM is rela-
tively rare, with a prevalence of about 0.7–0.8 % in
childhood, somewhat more frequent in girls [4] and bil-
inguals [5].
Selective mutism (SM) has over the years been found to
co-occur with other anxiety diagnoses (particularly social
phobia) and with neurodevelopmental disorders [6–9]. SM
is also reported to run in families, and a family history
study of 38 children with SM reported a clear excess of the
personality trait of taciturnity in 1st-, 2nd-, and 3rd-degree
relatives [10]. Support for a familial relationship between
generalized social phobia and SM was found in a large
study of parents to children with SM (70 parent dyads)
[11]. As a result of new knowledge, SM has been classified
as an anxiety disorder in the DSM-5, although upheld as a
separate diagnosis from social phobia due to frequent
comorbid language delays/disorders [12].
SM is considered to be hard to treat, and both medica-
tion and psychosocial treatments have been tried. With
regards to medication, a double-blind, placebo-controlled
study of children with SM from 1994 found that those
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treated with fluoxetine (n = 6) were rated as significantly
more improved than the non-medicated (n = 9) at the end
of the study period. However, most children in both groups
were still very symptomatic [13]. Similar findings were
reported in a retrospective 6–8 months naturalistic follow-
up study that included 17 children diagnosed with SM (16
with comorbid social phobia). Those who received treat-
ment with Selective serotonin reuptake inhibitors (n = 10)
showed greater improvement than unmedicated children
(n = 7), but the diagnoses persisted in 16 of the children
[14].
The psychosocial treatment literature for SM has been
dominated by case studies or case series including a wide
array of treatment approaches. Furthermore, data are scarce
both on the short-and long term outcome and predictors of
outcome. The few existing long term outcome studies are
usually retrospective, with few details provided about the
given treatment. Using retrospective patient records, per-
sisting communication problems were found in a sub-
stantial portion of 45 children with SM in a follow-up study
(mean 12 years) [15]. Although SM improved, a high rate
of psychiatric disorders was found in 33 adults with a
childhood SM diagnosis [16]. A severity indicator of SM,
taciturnity in the family and, by trend, immigrant status,
had an impact on psychopathology and symptomatic out-
come in young adulthood. In a retrospective study of 25
children, 2 to 10 years after referral, those given individual
programs with a behavioural component were more likely
to have improved compared with those given standard
school-based remedial programs. A further poor prognostic
indicator was past or present mental illness in the imme-
diate family [17]. In spite of the reported psychiatric
comorbidity [6–9] in children with SM, comorbidity as a
predictor for remission of SM has, to our knowledge not
been examined. Concerning comorbidity as a predictor of
outcome in Cognitive behavioral therapy (CBT) for
childhood anxiety disorders, results are not conclusive to
date. While a study of 173 children found that pretreatment
comorbidity was not associated with differences in treat-
ment outcome for the principal anxiety disorder diagnosis
[18], another study (n = 124) found that both total-and
non-anxiety comorbidity added to the prediction of diag-
nostic recovery [19].
In 2006, a comprehensive review of the psychosocial
treatment literature stated with some caution that CBT was
recommended for SM [20]. A study using a group CBT
approach for children with SM (n = 5), that also included a
second group for their parents (psychoeducation and advice
on how to handle SM) administered over an 8-week period,
reported symptom improvement post treatment in all par-
ticipants [21]. An alternating treatment design was applied
in nine children with SM showing greater effectiveness for
exposure based practice compared with contingency
management [22]. Children, parents, and teachers rated
outcome in terms of words spoken, and the reported effect
sizes suggested improvement by children and parents, with
somewhat less favourable teacher ratings. An established
cognitive behavioural treatment for childhood anxiety
disorders [23] was used in a case study of an 8 year old boy
with SM. Symptom improvement was notable after 21
sessions, and the gain was also maintained at 1 and
6 months follow-up appointments [24].
In recent years, CBT interventions especially adapted
for children with SM have been elaborated. The behav-
ioural components have been emphasized, as the symptom
of muteness and the young age of onset of SM make the
cognitive restructuring less feasible. An important factor
related to treatment is that children with SM tend to be
most symptomatic in the school environment [25], thus
requiring extensive treatment involvement of and coordi-
nation with teachers. Furthermore, as children with SM
often fail to speak to the therapist, a special strategy to
secure early child engagement as well as parental
involvement, is vital. Consequently, Lindsey Bergman
developed an integrated behavioral therapy for SM [26].
This treatment was conducted at the clinic with parental
participation using graduated exposure tasks to the feared
stimuli/situation (e.g. verbal communication). Therapists
also remained in communication with teachers to ensure
relevance of exposure tasks at school. A pilot Randomized
controlled study of this treatment (RCT) including 21
children (4–8 years of age) found improvement in number
of words spoken at school compared to baseline (blind
raters), although, significant group differences did not
emerge. However, a significant increase of speech was
found after treatment, with no change in wait-list controls,
as rated by the teacher on the School speech questionnaire
(SSQ) [4]. Furthermore, 67 % of treatment recipients no
longer fulfilled criteria for SM, and clinical gains were
maintained at 3 month follow-up [27]. Diagnostic comor-
bidity was not assessed in this study, but significant
reductions were reported in social anxiety symptoms per
parent, but not per teacher, report.
In contrast to this clinic based treatment, our adaption of
CBT for SM was the development of a school-based
intervention, as children with SM tend to be most symp-
tomatic in this environment [25]. To promote rapport with
the child, increase parental engagement, and train on pro-
cedures later to be used at preschool/school, we started the
treatment at home (three sessions), where these children
feel most safe. To decrease the often co-occurring social
anxiety, we used defocused communication as a general
treatment principle. Central components of defocused
communication are: to sit beside rather than opposite the
child; to create joint attention using an activity the child
enjoys rather than focusing on the child; to ‘think aloud’
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rather than asking the child direct questions; to give the
child enough time to respond rather than talking for the
child; to continue the dialogue even though the child does
not respond verbally; and try to receive a verbal answer in a
neutral way rather than praising the child. In line with
recommendations [20], we chose psychoeducation and
behavioural interventions. The psychoeducation (including
information about SM, and how to use defocused com-
munication) was given by phone with the teachers and
parents together to obtain a mutual understanding of SM
and the child’s level of functioning. The behavioural
interventions consisted of stimulus fading in the form of
gradually increased exposure, as well as contingency
management (use of positive reinforcement for speaking
behavior) to be applied in a joyful play activity inspired by
the Selective Mutism Resource Manual [28]. The behav-
ioural interventions took place at preschool/school twice a
week (each lasting half an hour) and followed six defined
modules/speaking levels according to the progress of the
child. The parents participated in the first module, the
teachers from modules III to VI and peers/classmates from
modules IV to VI. Table 1 describes the six modules (a
more thorough description of the intervention is available
in the RCT study [29]).
We found a highly favourable treatment outcome in a
pilot efficacy study of seven preschool children diagnosed
with longstanding SM (mean 20 months) [30]. Six children
spoke freely in all preschool settings after a mean of
14 weeks treatment, and treatment gains were maintained
at follow-up 1 year after end of treatment. Four bilingual
children were included in this study, counteracting bilin-
gualism as a negative outcome predictor.
We also found a significant treatment effect in an RCT
study, with no change in wait-list controls [29]. In this
study 24 children, 3–9 years of age, with a principal
diagnosis of SM (24 with comorbid social phobia, 16 with
additional diagnoses), were randomized to 3 months of
treatment (n = 12), or wait-list controls (n = 12). A time
by age interaction favoured younger subjects.
After 3 months of waiting, the children in the wait-list
group (n = 12) received the same treatment, thus rendering
a total of 24 children who were treated for a maximum of
6 months by local therapists (n = 21) at community health
clinics all over Southern Norway. The present article will
focus on the follow-up results from this effectiveness study
conducted 1 year after the end of 6 months treatment for
these 24 children with the teacher-rated SSQ and diag-
nostic status as primary outcome measures.
Based on the follow-up results from our pilot study we
did not expect a significant decline of effect at follow-up.
We also expected that the younger children would
remain more improved, and that severity of SM would be
associated with less symptom improvement (based on our
previous studies, and the early retrospective follow-up lit-
erature, respectively).
Due to both the situational nature of SM, and our
school-based intervention, we further hypothesized that the
children would show increased speaking behaviour pri-
marily on the SMQ school subscale, and not on the public
or at home subscales.
We also wanted to investigate whether diagnostic
comorbidity and familial SM had an impact. As our
treatment addresses SM, with the use of defocused com-
munication to decrease social anxiety, we did not expect a
treatment effect on the high rate of comorbid psychiatric
disorders, other than possibly social phobia. We did,
however expect a negative effect of familial SM, based on
the early retrospective follow-up literature.
Method
Design
This is a follow-up study conducted 1 year after the end of
a cognitive behavioural treatment adapted for children with
SM with data from the follow-up (T4), as well as from
baseline (T1), and after three- (T2) and six (T3) months of
treatment. No additional therapy was given before follow-
up. Table 2 presents an overview of informants and mea-
sures at T1 through to T4.
Participants
The sample consists of 24 children with SM, 3–9 years of
age [16 girls, mean age 6.5 years (sd 2.0), nine children
were in preschool; age 3–5 years, 15 were school children;
Table 1 Predetermined treatment modules reflecting increasingly
difficult speaking levels (I–VI) to be obtained in the preschool/school
setting from the baseline level of zero at T1; does not speak to adults
(as defined by the diagnosis of SM in this study)
Modules Description of the goal to be obtained in each speaking
level at school
I Speaks to the therapist (T) in a separate room with parent
(P) present
II Speaks to T in a separate room without P present
III Speaks to one teacher in a separate room with T present
IV Speaks to other teachers (and children) in a separate room
with T present
V Speaks to teachers (and children) in some settings without
T present (speaks to some, but not all adults and/or in
some groups in the classroom, but not in all larger
settings, such as full class
VI Speaks to teachers and children in all settings without T
present (normal speech, indistinguishable from other
children)
Eur Child Adolesc Psychiatry (2015) 24:757–766 759
123
age 6–9 years]. Six children were bilingual. At inclusion,
nonverbal IQ and receptive vocabulary (mean = 100,
sd = 15) was within the average range (mean/sd: 98/10
and 95/9, respectively, see our RCT study [29] for further
details). We asked specifically about SM in the following
family members: parents, siblings, grandparents, aunts/
uncles, cousins, as well as in more distant family members.
10 of the 24 families had a positive history of SM in family
members (in parents: n = 4, parents and siblings n = 1,
grandparents, aunts/uncles n = 5). In 23 families, one or
both parents described the presence of social anxiety
symptoms in their own childhood.
Inclusion criteria
Children aged 3–9 years, consecutively referred for SM
from outpatient Child and Adolescent Mental Health
Clinics (CAMHS) or school psychology services in
Southern Norway who fulfilled DSM-IV diagnostic criteria
for SM. In addition, we specified that the children should
not speak to adults in preschool/school, and that mutism
was present also in the native language for bilingual
children.
Exclusion criteria
(1) Parents who did not speak Norwegian or (2) children
with IQ \50, psychosis or a pervasive developmental
disorder. (3) Children on psychotropic medication or
receiving another active treatment for SM. This resulted in
34 age appropriate referrals. A screening procedure,
including anamnestic information and the Selective Mut-
ism Questionnaire (SMQ) [25] excluded ten children [due
to pervasive developmental disorder (n = 2), no mutism in
native language (n = 1), use of speech to some adults in
preschool/school (n = 7)]. The final inclusion of the 24
children was based upon a confirmation of the SM diag-
nosis after a home visit with a parental diagnostic interview
and a child assessment to rule out severe intellectual
problems.
Therapist recruitment and training
The 24 children in the present study were at inclusion
registered at a local CAMHS who then selected a local
therapist resulting in a total of 21 clinically experienced
therapists. All therapists had an advanced degree in mental
health (master level), including clinical/educational thera-
pists (n = 14), psychologists (n = 4), child psychiatrist
(n = 1), nurses (n = 2). All but one therapist had a mini-
mum of 5 years of clinical experience including no
(n = 4), some (n = 11), or extensive (n = 6) previous
work with selectively mute children. None had specific
CBT training. They used our detailed manual describing
defocused communication as a general treatment principle
and the behavioural interventions under close guidance and
supervision related to each session by phone from the first
or last author, with no further treatment adherence
measures.
Assessment instruments (see Table 2 for an overview of
measures used at T1–T4).
Diagnosis of SM and comorbid diagnoses
SM was diagnosed using the SM module from the semi-
structured anxiety disorders interview schedule (ADIS-IV)
[31] with good construct validity [32]. The SM module
relates to the speaking behaviour of the child in different
social situations. In addition, we gathered detailed infor-
mation on whether the child talked to adults in the pre-
school/school. To assess diagnostic comorbidity, we used
the revised version of the schedule for affective disorders
and schizophrenia for school-aged children: present and
lifetime version (K-SADS-PL) [33]. Nine children below
age 6 years were included, but adequate diagnoses can be
made as long as the behavioural concepts and the under-
standing of life interference is adapted to be relevant to a
preschool child [34]. Interviews were conducted by the last
author, with extensive experience with ADIS/K-SADS
interviews from research and clinical work, thus the diag-
nostic assessment at follow-up was not blinded.
Table 2 Overview of informants and measures used at baseline
(T1), after three- (T2) and six (T3) months of treatment, and 1 year
after end of treatment (T4)
Informants Time points for data collection
T1 T2 T3 T4

















SSQ school speech questionnaire, ADIS anxiety disorders interview
schedule (ADIS-IV), K-SADS-PL schedule for affective disorders and
schizophrenia for school-aged children: present and lifetime version,
CGI clinical global impression scale, SMQ selective mutism ques-
tionnaire, Life Events life events questionnaire, User Satisfaction
from a National Examination of Parental Satisfaction with Treatment
at CAHMS
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A measure of global impairment and improvement
We used a mother-rated clinical global impression scale
(CGI) [35], with a baseline rating indicating the severity of
illness (CGI-S) and a later improvement rating (CGI-I).
The CGI-S is a seven-point scale from: 1 = not at all a
problem; 2 = minimal problem; 3 = mild problem with
some impact on the child’s functioning; 4 = moderate
problem with an impact on the child’s functioning;
5 = marked problem that limits the functioning of the
child; 6 = severe problem, the child can only function with
help; and 7 = very severe problem, not functioning. The
CGI-I also uses a seven-point scale that describes the
improvement/worsening of symptoms relative to baseline:
1 = very much improved; 2 = much improved;
3 = minimally improved; 4 = no change; 5 = minimally
worse; 6 = much worse; and 7 = very much worse.
SM questionnaires
The School Speech Questionnaire (SSQ) [4] Our primary
outcome measure was the SSQ (based on speech frequency
in the school context) rated by the child’s teacher at T1 to
T4, as it was expected that teachers would have the most
accurate information on speaking behaviour in this setting.
The SSQ, a quantitative measure with no cutoff score,
includes ten questions and is modified from the SMQ (see
below) with acceptable internal consistency. Six of the
SSQ questions (identical to the SMQ) are used to compute
a mean score (range = 0–3), computed as the mean of the
valid items, if at least half the items were valid. As in the
SMQ, 0 indicates that speaking behaviour never occurs,
and 1, 2 and 3 refer to seldom, often and always speaking,
respectively. We used the Norwegian translation with
permission from Lindsey Bergman, the developer of the
measure. Internal consistency was somewhat low, but
acceptable (a = 0.64).
The Selective Mutism Questionnaire (SMQ) [25] The
(SMQ) was rated by mothers at the same time-points
(T1–4) for two reasons; to have multiple raters of speaking
behaviour in the preschool/school setting, and to look at
possible changes in two additional settings (at home and in
public). The SMQ includes 32 questions scored from 0–3,
where 0 indicates that speaking behaviour never occurs,
and 1, 2 and 3 refer to seldom, often and always speaking,
respectively. 17 of the SMQ questions are used to compute
three subscale mean scores [preschool/school (six items), at
home (six items) and in public (five items)] with the same
0–3 scoring range, computed as the mean of the valid
items, if at least half the items were valid. The SMQ total
factor score was computed from the sum of three subscales
divided by three. In this study, one child had one missing
item on one subscale. We used the Norwegian translation
with permission from Lindsey Bergman, the developer of
the measure. Acceptable internal consistency was found for
the three subscales and the total score, respectively
(a = 0.68, 0.73, 0.76, 0.77).
The SMQ has no cut-off score, but a psychometric study
suggests a score B0.5 on the School and Public SMQ
subscales for children with SM compared to C2.5 for
children without SM [25].
Additional measures at follow-up (T4) The mothers
completed a modified version of the Life events question-
naire for adolescents [36] comprising 37 statements about
the child’s life events from T3 to T4. Among the 37
statements, 25 are considered negative life events, 12
positive/ambiguous. One is asked to indicate whether each
event had occurred or not, and to indicate an overall impact
of the reported events combined on a scale from 0 (no
distress) to 3 (severely distressed).
The mothers also completed a measure of parental sat-
isfaction with the treatment previously used in a national
CAMHS examination [37]. Presented here are the two
questions pertaining to the overall satisfaction/dissatisfac-
tion with the treatment offered to the child, and to how the
parents were treated as caretakers during the process. The
questions were rated on a scale from 1 (very dissatisfied) to
5 (very satisfied).
Ethical approval
Written informed consent was provided by the parents. The
study was granted approval by the Norwegian Social Sci-
ence Data Services and the Regional Committees for
Medical and Health Research Ethics.
Missing data
There were no missing data on T1–T4. One child only
received treatment for 3 months due to travelling abroad,
but completed all assessments.
Data analysis
Descriptive statistics using mean (standard deviation) or
number of patients are presented for the SM questionnaires
(SSQ, SMQ), the CGI, life events, user satisfaction and the
diagnoses.
A linear mixed model for repeated measurements was
applied to investigate the questionnaire total- and subscale
scores from baseline (T1), 3 months (T2), 6 months (T3),
and follow up 1 year after end of treatment (T4). Effect of
age at diagnosis and severity of SM was examined as
covariates. Mean differences between the four time points
Eur Child Adolesc Psychiatry (2015) 24:757–766 761
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(T1–T4) were tested using Bonferroni corrections. The
level of significance was defined as p\ 0.05. As we found
a low number of life events from T3 to T4 (mean 2.0, sd
1.86) not indicated by mother to represent any distress
(mean 0.70, sd 0.80), life events were not included in the
model.
A one-way ANOVA with Tukey post hoc comparisons
was used to test for differences in the CGI-Improvement
rating at follow-up (T4) between the SM related diagnostic




On our primary outcome measure, the teacher-rated SSQ,
there was no significant decline of effect at follow-up. On
the contrary, we found a small but significant increase in
scores over time (F3,69 = 16,055, p\ 0.001), indicative of
further improvement. The significant increase took place
from T1 to T2 [mean difference 0.52 (95 % CI 0.17–0.87,
p = 0.001)]. Mean scores on the SSQ are presented in
Table 3.
School Speech Questionnaire (SSQ) results further
indicated a more pronounced increase in speech in younger
children. In the model that also included age as a covariate
and a time by age interaction, there was a significant effect
of age (F1,22 = 4.843, p = 0.039) and a time by age
interaction (a steeper increase of SSQ with time in younger
children) (F3,66 = 5.016, p = 0.003), but still significant
for time (F3,66 = 10.708, p\ 0.001). Finally, we found a
significant effect of SM severity (less effect in more severe
cases) (F1,21 = 12.492, p = 0.002), as measured by SSQ
scores at diagnosis, when it was included in the model.
However, a significant effect of time (F1,21 = 17.597,
p\ 0.001), age (F1,21 = 7.925, p = 0.010) and time by age
interaction (F3,66 = 5.018, p = 0.003) was still present.
The SSQ findings were in general replicated on the
mother-rated SMQ. The SMQ total score showed a sig-
nificant increase in scores over time (F3,69 = 28.494,
p\ 0.001) with the most pronounced increase from T1–T2
(mean difference 0.44 [95 % CI 0.19–0.69, p\ 0.001]).
However, increased speech was not restricted to the school
setting. Using the SMQ subscale scores, measuring
speaking behaviour at school, at home and in public,
respectively, they all showed significant increases over
time (p\ 0.001, statistics not shown). See Table 3 for
mean SMQ scores. The effect of age on the SMQ total
score was not significant and therefore not included in this
model. A borderline significance (p = 0.0053) of age was
found on the SMQ school subscale, with no age effect on
the other two subscales measuring speech behaviour at
home and in public (p[ 0.62).
Diagnostic status and clinical global improvement
At follow-up, 12 children (50 %) no longer fulfilled diag-
nostic criteria for selective mutism (SM), as they spoke
freely at school (nine of the 16 girls and three of the eight
boys). Another four children spoke freely in some, but not
all settings at school, and/or to some, but not all adults.
Thus, rigorously speaking they did not fulfil the DSM-IV
criteria of ‘‘Consistent lack of speech’’ and were catego-
rized as SM in remission. The remaining eight children
fulfilled diagnostic criteria for SM. A one-way ANOVA
showed that these three diagnostic groups differed signifi-
cantly on the CGI-Improvement scale (F2,21 = 15.19,
p\ 0.001). Tukey post hoc comparisons indicated that the
eight children diagnosed with SM at follow-up (M = 3.0
95 % CI 2.37–3.63) differed significantly, both from the
four children with SM in remission (M = 1.75, 95 % CI
0.95–2.55, p = 0.008), and from the 12 children with no
SM (M = 1.50, 95 % CI 1.17–1.83 p\ 0.001). The dif-
ference between the children with SM in remission and
children with no SM was not significant (mean 1.75 and
1.50, respectively, p = 0.58).
Table 3 SM questionnaires
with data from baseline (T1)
through to follow-up 1 year




clinical global impression scale
including a severity- and an
improvement rating








Teacher SSQ 0.55 (0.43) 1.07 (0.83) 1.25 (0.86) 1.38 (0.78)
Mother SMQ-school 0.50 (0.40) 1.03 (0.70) 1.23 (0.80) 1.47 (0.74)
SMQ-at home 1.65 (0.64) 2.11 (0.47) 2.19 (0.57) 2.42 (0.45)
SMQ-in public 0.33 (0.43) 0.63 (0.53) 0.88 (0.70) 1.04 (0.74)
SMQ-total
score




2.75 (1.03) 2.04 (0.91)
762 Eur Child Adolesc Psychiatry (2015) 24:757–766
123
Using the diagnoses, we again found a more prominent
improvement in the younger children, as seven of nine
children (78 %) aged 3–5 years at inclusion did not fulfil
criteria for SM at follow up, compared with five of fifteen
children (33 %), 6–9 years of age at inclusion. Pretreat-
ment comorbidity had no impact on remission of SM at
follow-up, as 50 % of both baseline noncomorbid (N = 8)
and comorbid (N = 16) participants were diagnosed
without SM.
At follow-up, comorbid anxiety diagnoses, as assessed
by KSADS, were still frequent. Diagnoses other than social
phobia were evenly distributed in children with and with-
out SM at follow-up. In five children diagnosed without
SM, there was also remission of social phobia (see
Table 4). There was no negative effect of having SM in the
family, as five of the ten children with familial SM (50 %)
did not fulfill criteria for SM at follow-up.
User satisfaction
The mothers reported an overall satisfaction with the
treatment offered to the child [mean 4, 7 (sd 0.5), range
3–5], and with how the parents were treated as caretakers
in the process [mean 4.9, (sd 0.3), range 4–5].
Discussion
To our knowledge, this is the first prospective follow-up
study conducted 1 year after the end of a cognitive
behavioural treatment for children with SM in a reasonably
large sample (in the context of prior SM studies).
As hypothesized, treatment gains were maintained at
follow-up (T4). Furthermore, we found, as expected that
younger children had greater improvement. This was
shown both on our primary outcome measure (the teacher-
rated SSQ), and by the fact that a greater proportion of the
younger children (aged 3–5 years) no longer met diag-
nostic criteria for SM. As expected, we also found that
severity of SM, as measured by SSQ at baseline, had a
significant effect upon outcome at follow-up, thus con-
firming findings from a retrospective long term outcome
study [16]. This finding is also in line with recent findings
from the large childhood anxiety disorder treatment study
(CAMS) [38]. However, although the participating children
had a high load of familial social phobia and SM, in line
with retrospective follow-up studies [10, 15], we could not
confirm the effect of familial SM upon outcome in the
present study.
Contrary to our expectations, significantly improved
speaking ratings were reported on all SMQ subscales, not
only on the school subscale, as found in our previous
studies [29, 30]. Due to a possibly less entrenched mutism
in younger subjects, it seems plausible that a younger age
at inclusion seems to predict more improvement in the
preschool/school environment. Furthermore, an effect of
age at inclusion is congruent with the earliest SM literature
suggesting that an early intervention may have been par-
ticularly important for those who improved with treatment
[6, 39]. As the effect of age at inclusion was not examined
in the Bergman study [27], we cannot compare our findings
on this matter.
However, compared with the Bergman study [27], we
had a smaller percent who no longer fulfilled criteria for
SM (50 versus 67 %, respectively). This could simply
reflect weaker results, as the children in our study were
treated by local therapists, without prior CBT experience.
In the Bergman study, the therapists were CBT trained,
working at one clinic under direct guidance by the principle
investigator, resulting in an excellent treatment adherence.
Unfortunately, no formal treatment adherence measure was
included in the present study, excluding the assessment of
possible outcome variance due to therapist differences in
adherence.
Our results could also be influenced by other factors.
First, our sample was approximately 1 year older, and
seemed to have a more severe SM (as measured by lower
SSQ at inclusion (mean 0.55 versus 0.81, respectively).
To define what constitutes a clinically meaningful
symptom improvement, and the definition of the criteria for
SM diagnosis, are both challenging issues. First, the pres-
ent study found a significant statistical improvement in
speaking behaviour. One could expect that the level of











Selective mutism N = 24 N = 12 12 0
Social phobia N = 24 N = 19 12 7
Separation anxiety N = 7 N = 4 3 1
Specific phobia N = 6 N = 2 1 1
Generalized anxiety
disorder
N = 2 N = 3 2 1
OCD N = 2 N = 0 0 0
Tics N = 2 N = 1 0 1
Enuresis N = 6 N = 3 2 1
Encopresis N = 1 N = 0 0 0
Total N of children
with diagnoses other
than SM and social
phobia
N = 16 N = 11 5 6
Column 3 and 4 present diagnoses in children with (N = 12), and
without (N = 12) SM at T4, respectively
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speaking should approach a normal speaking behavior to
represent clinical meaningfulness. We found that the mean
teacher reported SSQ results changed from a level between
never to seldom (0.55) to a level between seldom to often
(1.38). Although lower than what is expected in children
without SM (a level between often to always), we would
argue that this change represents a clinically significant
improvement for a child with SM. Secondly, concerning
the diagnostic criteria of SM, the DSM does not specify
whether the ‘‘Consistent lack of speech’’ means that some
speaking in class (like in smaller groups of students, alone
with teacher, or with teachers and children in smaller
groups) is sufficient to avoid SM diagnosis. In the present
study, we chose to categorize the four children who at
follow-up spoke freely in some, but not all school settings
as still having SM, but in remission. Due to their need for
accommodation from others in some situations and the
resulting lack of independence, we considered this repre-
sented an impairment qualifying for a diagnosis. However,
an important point is that the CGI-improvement score at
follow-up indicated that these four children were more
similar to the children who no longer fulfilled diagnostic
criteria for SM (N = 12), than to the children who were
diagnosed with a definite SM (N = 8). If these four chil-
dren were assigned to the no SM group, our results were
comparable to the Bergman study. These issues also speak
to the need for further refinement of the diagnostic criteria
for SM. Even in the DSM-5 [12], it is not clear whether
children with consistent lack of speech in some areas, but
not others, would be considered to meet diagnostic criteria
or not.
In line with a study on CBT for child anxiety disorders
[18], pretreatment comorbidity was not associated with
differences in remission of SM after treatment. As expec-
ted, our intervention did not have an effect upon comorbid
psychiatric diagnoses, which were frequent at both T1 and
T4. Interestingly, however, five children who no longer
fulfilled criteria for SM also showed remission of social
phobia (see Table 4), consistent with the notion that for
many children with comorbid SM and social phobia, these
two ‘‘disorders’’ are one in the same.
Although the present study found a small, but steady
improvement over time, the most improvement took place
from T1 to T2 (after 3 months of treatment). Interestingly,
this finding seems to be in line with the reported mean
results in the Bergman study. We cannot say for sure
whether this is to be expected, whether therapy could end
at this time point, or whether it indicates that something
else, or a more intensified treatment is necessary from T2.
One could also always question whether the increased
speech observed after 3 months is a result of treatment or
not. A strong indication for the effect of treatment is the
lack of change after 3 months in the waitlist controls in the
two RCT-studies to date [27, 29]. The children in the
present study were not reported to have experienced much
in the way of stressful life events from T3 to T4, or to have
received any other form of treatment in the year following
end of therapy with a likely effect on functioning.
Although the present study can show a significantly
increased speech in the group as a whole, half the subjects
continued to fulfill diagnostic criteria for SM. Comorbid
anxiety disorders were still frequent, both in participants
with and without SM. This study only included an inter-
vention targeted specifically at SM. Whether a more broad
intervention, including in particular specific exposure tasks
for social phobia would be more effective, remains to be
seen. Nonetheless, this study demonstrates that a cognitive
behavioural school-based treatment can be effective for
SM in children aged 3–9 years. The therapists used treat-
ment including defocused communication as a general
treatment principle, and a home and school-based inter-
vention with gradual exposure to the feared situations in
which speech is expected. Particularly promising is the fact
that we could observe a significant effect in the hands of
therapists who were not experts in SM. In addition, the
favourable user satisfaction points to the feasibility of the
intervention. Future research is needed to ascertain the
active treatment components. For older children with SM,
how to best utilize available school resources seems crucial
to explore further, as also pointed out in the Bergman study
[27]. Given the favourable results from this clinic-based
study, we could hardly claim that a school-based inter-
vention, such as ours, is necessary when treating SM.
However, it gives direct access to the most important
people (children and adults at school) related to the training
of the child’s speaking behavior, and one form of a par-
ticularly close cooperation with the school, is underscored
in both studies. Another similarity is the emphasis put on
child and parent engagement, and the use of gradually
exposure to the feared stimulus (e.g. speaking).
Limitations
The sample size is a limitation. Second, the outcome raters
were not blind to whether treatment had taken place. Third,
the lack of a blind assessment of treatment adherence is
also a limitation.
Finally, in the present study, we chose a school based
intervention, that is to work at the arena where the symp-
toms are most pronounced and thus most impairing for the
child. However, this might represent a limitation, as this
treatment may not be easily translated to a general practice
in the office settings.
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Conclusions
This is the first prospective follow-up study conducted
1 year after end of a cognitive behavioural treatment for
children with SM, in a reasonably large sample (e.g. in the
context of SM). Clinical gains were maintained at follow-
up. Although increased speech and global improvement
was found after treatment, a substantial number of children
continued to meet criteria for SM, and comorbid diagnoses
were still frequent.
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